NueCura in the News

A great article about NueCura Partners, LLC about the good work we are doing.  Milt Capps continues to be a great supporter of the Nashville Angel groups!

 

Read the full article HERE:

NueCura Partners, LLC Invests in RxREVU

NASHVILLE, Tenn., Apr. 22, 2015 /PRNewswire-iReach/ — NueCura Partners, LLC has added the rapidly growing Denver based start-up, RxREVU, to its portfolio. “We’re tremendously excited to partner with RxREVU. Their software represents an extraordinary new approach to prescribing, and will greatly assist doctors and patients in finding the right medication at the right price,” says Ted Sanft, Operating Partner at NueCura.

RxREVU helps consumers and providers find the best drugs available based on cost, condition, and clinical research. Their mission is to help people live happier and healthier lives by finding the most effective treatment at the lowest cost. The company is trail-blazing the use of predictive analytics to help analyze medications based on unique patient factors, such as age, gender and ethnicity.

“Working with NueCura Partners was a great experience all around. Their team brings a deep understanding of the healthcare industry and clearly understands the need for our technology,” said Carm Huntress, CEO of RxREVU, Inc. “We’ve met with many early stage investment groups and could not be more impressed with the partners’ backgrounds, connectivity to the Nashville healthcare community and support they’ve already given us as an early stage company” said Huntress.

NueCura Partners, LLC is a Nashville-based angel investment group that focuses on early-stage investment opportunities in the healthcare sector. NueCura is managed by seasoned healthcare business operators and leverages their experience to identify and finance breakthrough technologies in the healthcare space. You can learn more about RxREVU at www.rxrevu.com.

Media Contact: Susan Francisco, RxREVU, Inc., (800) 360-4965, susan.francisco@rxrevu.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE RxREVU

 

MEDarchon Lands Strategic Client

NASHVILLE, Tenn.–(BUSINESS WIRE)–MEDarchon, Inc. today announced that Massachusetts Eye and Ear, a teaching affiliate of Harvard Medical School, has continued its focus on care coordination and patient safety by choosing QUARC as its secure messaging and communication platform. Mass. Eye and Ear is consistently ranked as one of the nation’s leading hospitals for both ophthalmology and otolaryngology.

Annually Mass. Eye and Ear sees roughly 220,000 outpatient visits and performs over 22,000 surgical procedures, and the organization only expects these numbers to grow. As patient volume increases and safety and security guidelines become more stringent, MEDarchon’s QUARC secure messaging and communication platform will fulfill the communication needs of Mass. Eye and Ear clinicians in a way that saves time, fits into the natural clinical workflow, and promotes care coordination and patient safety. QUARC will be integrated with the hospital’s call scheduling system to ensure that patient data is up to date and that messages are sent, routed, and escalated to the most appropriate clinician and members of the patient Care Team.

QUARC will allow Mass. Eye and Ear to securely send messages from the web or mobile smart phone applications. QUARC messages can be automatically routed and escalated based on the hospital’s preferences, the on-call schedule, and the priority given to each message. Clinicians have the option in QUARC to create and send messages about a specific patient or to simply send a direct message to another clinician or member of the staff. MEDarchon worked closely with Mass. Eye and Ear to develop a “Mass Notification” feature within QUARC that enables enterprise-wide emergency communication across multiple platforms to all employees. Having the ability to quickly and efficiently communicate emergency information was particularly important to Mass. Eye and Ear after the Boston Marathon tragedy.

MEDarchon did extensive research on patient safety to fully understand the role that communication failures play in causing medical errors when developing QUARC. As a result, QUARC has layered in functionality, usability and analytics designed to help prevent medical errors caused by communication breakdown.

QUARC is the secure solution for safe and efficient healthcare communications. Its modules include smartphone-based paging, secure texting, patient hand-offs, on-call scheduling, and mass alerts. Designed by clinicians and administrators, QUARC’s functionality, usability, and big data analytics were created to prevent medical errors, improve organizational efficiency, and provide an unmatched level of security.

NueCura Partners Fund MEDArchon

NueCura Partners, LLC has participated in MEDArchon’s series B round as reported by Venture Nashville.  Please follow the link HERE for the full story.

NueCura Partners joins the Angel Capital Association

NueCura Partners is pleased to announce that we have joined the Angel Capital Association. The Angel Capital Association is the leading professional and trade association supporting the success of angel investors in high-growth, early-stage ventures.

The ACA provides a plethora of services to it’s members including educational resources for investing, access to a vibrant community of angel investor groups and individual angel investors, and access to enhanced deal flow and through the ACA network affiliation.

ACA benefits are extended not only to our NueCura Partners group but to each affiliate investor in our membership.

 

Angel Capital Association Logo